Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Active Not Recruiting Phase Trials for Melphalan (DB01042)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Active Not RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00856388Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersTreatment